|   In the News

Wotton replaces Gilman as CEO of cell, gene therapy startup Obsidian


Obsidian Therapeutics has named Paul Wotton as CEO. The appointment gives Obsidian a full-time CEO following a period in which Michael Gilman helmed the biotech while also running Arrakis Therapeutics.

Read more.